Live Breaking News & Updates on Liquid Hexavalent Vaccine

Stay updated with breaking news from Liquid hexavalent vaccine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Panacea Biotec files suit against Sanofi for patent infringement


Panacea Biotec files suit against Sanofi for patent infringement
SECTIONS
Last Updated: May 17, 2021, 02:48 PM IST
Share
Synopsis
The suit filed against Sanofi comes at the heels of Sanofi having received marketing approval for a Whole Cell Pertussis based Hexavalent vaccine by the Drugs Controller General (India), Panacea Biotec said in a regulatory filing.
Reuters
Panacea Biotec on Monday said it has filed a suit before the Delhi High Court seeking to restrain
Sanofi Healthcare India from marketing a fully liquid hexavalent vaccine. The national capital-based firm said a case has been filed in order to stop infringement of its patent for fully liquid whole cell pertussis based fully liquid Hexavalent vaccine EasySix. ....

Indian Patent Office , Delhi High Court , Whole Cell Pertussis , Drugs Controller General , Delhi High Courts , Whooping Cough , Panacea Biotec , Liquid Hexavalent Vaccine , Drugs Controller , இந்தியன் காப்புரிமை அலுவலகம் , டெல்ஹி உயர் நீதிமன்றம் , மருந்துகள் கட்டுப்படுத்தி ஜநரல் , டெல்ஹி உயர் நீதிமன்றங்கள் , ஹூப்பிங் இருமல் , சஞ்சீவி பயோடெக் , மருந்துகள் கட்டுப்படுத்தி ,